COCA-COLA EUROPACIFIC PARTNE
CCEPNASDAQ๐ #246 by market capEarnings Feb 18US Equity
$115.53โฒ $0.86 (+0.75%)
Market closed ยท at closeTrack CCEP
Get earnings, price moves & breaking news on Telegram
24hโฒ 0.8%
7dโ
14dโ
30dโ
ytdโ
1yโ
๐ฆMarket Cap
$50.81B
Mid Cap
๐Revenue Growth (YoY)
11.7%
Healthy
๐Gross Margin
36.3%
Healthy
๐ตFCF Margin
6.3%
Moderate
โ๏ธP/S Ratio
1.4x
Cheap
Otter Score
80
Strong
COCA-COLA EUROPACIFIC PARTNE
CCEPAnalyst Ratings
Price
$115.53
Total
28
Raised
4
Lowered
6
Avg PT
$111.00
H / L
$115 / $107
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Barclays | Reiterated | Overweight | 2026-11-05 | $112.00 | โ3.10% |
UBS | Reiterated | Neutral | 2026-11-04 | $107.00 | โ7.40% |
Wells Fargo | Reiterated | Overweight | 2026-11-04 | $115.00 | โ0.50% |
Evercore ISI Group | Reiterated | Outperform | 2026-11-04 | โ | โ |
JP Morgan | Reiterated | Neutral | 2026-02-18 | โ | โ |
Goldman Sachs | Reiterated | Buy | 2026-02-18 | $110.00 | โ4.80% |
B of A Securities | Downgraded | Buy โ Neutral | 2026-01-14 | โ | โ |
Deutsche Bank | Reiterated | Buy | 2024-09-09 | $114.00 | โ1.30% |
Argus Research | Reiterated | Buy | 2024-03-19 | $85.00 | โ26.40% |
Exane BNP Paribas | Upgraded | Neutral โ Outperform | 2024-01-12 | โ | โ |
Societe Generale | Upgraded | Sell โ Hold | 2023-04-26 | $42.50 | โ63.20% |
HSBC | Upgraded | Hold โ Buy | 2021-05-19 | $70.00 | โ39.40% |
ABN Amro | Upgraded | Hold โ Buy | 2020-07-06 | โ | โ |
CFRA | Reiterated | Hold | 2020-02-14 | $82.00 | โ29.00% |
Morgan Stanley | Downgraded | Overweight โ Equal Weight | 2019-06-12 | $87.00 | โ24.70% |
Susquehanna | Reiterated | Neutral | 2018-10-25 | โ | โ |
Macquarie | Reiterated | Outperform | 2018-09-14 | โ | โ |
Bank of America | Reiterated | Buy | 2018-09-13 | โ | โ |
Argus | Downgraded | Buy โ Sell | 2018-05-05 | โ | โ |
Citigroup | Downgraded | Buy โ Neutral | 2017-04-28 | $57.00 | โ50.70% |
Stifel Nicolaus | Downgraded | Buy โ Hold | 2016-12-06 | โ | โ |
Kepler Cheuvreux | Reiterated | Buy | 2016-10-20 | โ | โ |
Credit Suisse | Reiterated | Neutral | 2016-09-15 | $60.00 | โ48.10% |
CLSA | Reiterated | Outperform | 2016-06-01 | โ | โ |
Jefferies | Reiterated | Hold | 2016-01-25 | โ | โ |
Nomura | Downgraded | Neutral โ Reduce | 2014-10-31 | โ | โ |
ISI Group | Reiterated | Neutral | 2014-05-28 | โ | โ |
RBC Capital | Reiterated | Outperform | 2013-11-26 | โ | โ |
Institution
Barclays
Reiterated ยท Overweight ยท 2026-11-05
$112.00
โ3.10%
UBS
Reiterated ยท Neutral ยท 2026-11-04
$107.00
โ7.40%
Wells Fargo
Reiterated ยท Overweight ยท 2026-11-04
$115.00
โ0.50%
Evercore ISI Group
Reiterated ยท Outperform ยท 2026-11-04
โ
โ
JP Morgan
Reiterated ยท Neutral ยท 2026-02-18
โ
โ
Goldman Sachs
Reiterated ยท Buy ยท 2026-02-18
$110.00
โ4.80%
B of A Securities
Downgraded ยท Buy โ Neutral ยท 2026-01-14
โ
โ
Deutsche Bank
Reiterated ยท Buy ยท 2024-09-09
$114.00
โ1.30%
Argus Research
Reiterated ยท Buy ยท 2024-03-19
$85.00
โ26.40%
Exane BNP Paribas
Upgraded ยท Neutral โ Outperform ยท 2024-01-12
โ
โ
Societe Generale
Upgraded ยท Sell โ Hold ยท 2023-04-26
$42.50
โ63.20%
HSBC
Upgraded ยท Hold โ Buy ยท 2021-05-19
$70.00
โ39.40%
ABN Amro
Upgraded ยท Hold โ Buy ยท 2020-07-06
โ
โ
CFRA
Reiterated ยท Hold ยท 2020-02-14
$82.00
โ29.00%
Morgan Stanley
Downgraded ยท Overweight โ Equal Weight ยท 2019-06-12
$87.00
โ24.70%
Susquehanna
Reiterated ยท Neutral ยท 2018-10-25
โ
โ
Macquarie
Reiterated ยท Outperform ยท 2018-09-14
โ
โ
Bank of America
Reiterated ยท Buy ยท 2018-09-13
โ
โ
Argus
Downgraded ยท Buy โ Sell ยท 2018-05-05
โ
โ
Citigroup
Downgraded ยท Buy โ Neutral ยท 2017-04-28
$57.00
โ50.70%
Stifel Nicolaus
Downgraded ยท Buy โ Hold ยท 2016-12-06
โ
โ
Kepler Cheuvreux
Reiterated ยท Buy ยท 2016-10-20
โ
โ
Credit Suisse
Reiterated ยท Neutral ยท 2016-09-15
$60.00
โ48.10%
CLSA
Reiterated ยท Outperform ยท 2016-06-01
โ
โ
Jefferies
Reiterated ยท Hold ยท 2016-01-25
โ
โ
Nomura
Downgraded ยท Neutral โ Reduce ยท 2014-10-31
โ
โ
ISI Group
Reiterated ยท Neutral ยท 2014-05-28
โ
โ
RBC Capital
Reiterated ยท Outperform ยท 2013-11-26
โ
โ
One row per institution ยท price target from the firm's latest published target